Navigation Links
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Date:9/19/2011

th breast cancer receiving aromatase inhibitor therapy.(i)

In men, bone mineral density (BMD) was significantly higher at the lumbar spine in patients treated with Prolia for two years compared to placebo (-1.0 percent placebo, +5.6 percent Prolia; treatment difference 6.7 percent [95 percent CI: 6.2, 7.1]; P<0.0001). Additionally, after three years of treatment with Prolia, differences in BMD were 7.9 percent at the lumbar spine, 5.7 percent at the (total) hip and 4.9 percent at the femoral neck and the incidence of new vertebral fractures was 3.9 percent in the placebo-treated men compared to 1.5 percent for the Prolia-treated men, representing a relative risk reduction of 62 percent (P=0.0125).

In women, BMD was higher at 12 months at the lumbar spine in patients treated with Prolia as compared to placebo (-0.7 percent placebo, +4.8 percent Prolia; treatment difference 5.5 percent [95 percent CI: 4.8, 6.3]; P<0.0001). Additionally, after two years of treatment with Prolia differences in BMD were 7.6 percent at the lumbar spine, 4.7 percent at the (total) hip and 3.6 percent at the femoral neck.

The most common (per patient incidence > 10 percent) adverse reactions reported with Prolia in patients with bone loss receiving androgen deprivation therapy for prostate cancer or adjuvant aromatase inhibitor therapy for breast cancer are arthralgia and back pain.  Pain in extremity and musculoskeletal pain have also been reported in clinical trials.  Additionally, in Prolia-treated men with non-metastatic prostate cancer receiving androgen deprivation therapy, a greater incidence of cataract adverse events was reported. Hypocalcemia was reported in Prolia-treated patients.

About Prolia

Prolia is the first approved therapy that specifically targets RANK Ligand, an essential regulator of osteoclasts (the cells that break down bone).

Prolia is approved in the U.S. for the treatment of postmenopausal
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, will ... dbAccess Health Care Conference in Boston.   The ... a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation ... website at http://www.neurocrine.com . If you ...
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013 Hearing health ... active, feel younger, and remain socially and professionally engaged, he ... is the overriding message that the Better Hearing Institute ... support of National Men,s Health Week , which leads ... Health Week runs from June 10 through June 16. ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
(Date:5/24/2013)... Bethany Beach, Delaware (PRWEB) May 24, 2013 ... Tammy Mushrush has joined the Dayna Feher team at ... Pa., Mushrush made the Delaware resorts her home in ... she has since worked in all aspects of the ... operations, and for the past 12 years, a licensed ...
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group ... more than 59,229 complaints since 2004 from women claiming they ... known as the Mirena IUD.* , Among the most common ... ‘expulsion,’ where the IUD came out on its own. There ... News article. “Abdominal pain is also common, with 3,774 complaints. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 CHI-California ... Appropriators and the California congressional delegation, joined by ... sequestered industry user fees paid to the U.S. ... ensure that future across-the-board cuts will not include ... the FY14 Agriculture, Rural Development and FDA Appropriations ...
(Date:5/24/2013)... May 24, 2013 Started in 1982, AMTC’s ... in Orlando. 2013 marks AMTC’s 31st anniversary. SHINE is a ... with supermodel Millie Lewis and her daughter, Carey Lewis Arban. ... managers, casting directors, and music professionals including the New York ... XP Media. They are kings of Hollywood and Christian casting ...
(Date:5/24/2013)... 24, 2013 Area homeowners dreaming about owning ... hot tubs to choose from at factory-direct pricing during the ... sales event takes place at Emerald Pool and Patio ... , Jacuzzi, the industry's leading hot tub brand, scheduled the ... country. The event will feature popular hot tub models at ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... to be held Wednesday, September 16, 2009 LOS ... Summit Entertainment, will be honored at the 35th annual ... California Chapter of the National Multiple Sclerosis Society. ... 16, 2009 at the Century Plaza Hotel in Los ...
... the annual meeting of the American Academy of Neurology ... , Like a quiz show, Neurobowl awards points for ... wrong answers. The tougher the question, the higher the ... neurological conditions, based on symptoms, video clips, X-rays, etc. ...
... April 16 JAZD Markets, the leader in on-line B2B ... platforms, today announced that David Southwick has joined the company ... Southwick will be focused on building out JAZD Markets, sales ... trade associations. "Dave brings a proven career of building ...
... SACRAMENTO, Calif., April 16 The California ... 31 deadline is rapidly approaching to have your kindergartener ... the 2009-10 school year.The requirement has been in effect ... most common chronic childhood disease, it is essential that ...
... Lamb & Apples WellBars Guaranteed to Make Dogs Even Happier ... responsible pet parents who want to show their dogs a ... Wellness WellBars flavors to choose from. The ... announces the availability of two NEW meat-based varieties ...
... Chosen to Accurately Identify Donors at Allahabad ... M2SYS Technology, an award-winning fingerprint biometrics research ... Enterprise Solutions has integrated M2SYS, Bio-Plugin(TM) fingerprint ... blood donor management system. The biometric ...
Cached Medicine News:Health News:The National Multiple Sclerosis Society's 35th Annual Dinner of Champions to Honor Summit Entertainment's Rob Friedman 2Health News:What do neurologists do for entertainment? 2Health News:JAZD.net Adds David Southwick as SVP of Sales and Service 2Health News:California Dental Association Reminds Parents of Kindergarten Dental Check-Up Requirement 2Health News:New Wellness(R) WellBars(R) Dog Snack Flavors Receive a Round of 'Paw-pplause' 2Health News:M2SYS Fingerprint Biometrics System Selected by VinDec Enterprise Solutions to Verify Blood Donors 2
... PoliPhase® is a biologically based adhesive ... component system consisting of a liquid ... control of internal bleeding. ... flow on to a prepared wound ...
... Topical Skin Adhesive gives you new options ... intended for topical application only to hold ... from surgical incisions, including punctures from minimally ... lacerations. DERMABOND adhesive may be used in ...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
Redwood Toxicology Laboratory is one of the world's premier forensic drug detection laboratories offering its customers scientifically accepted, legally defensible drug detection services....
Medicine Products: